Last reviewed · How we verify
The Study of a Selective Serotonin Partial Agonist and Reuptake Inhibitors, HEC113995PA•H2O,in Healthy Subjects
This study is a safety, tolerability, and pharmacokinetics phase Ⅰstudy of a selective Serotonin partial agonist and reuptake inhibitors, HEC113995PA•H2O,in healthy subjects.This study is the healthy adult subjects single ascending-dose research.
Details
| Lead sponsor | Sunshine Lake Pharma Co., Ltd. |
|---|---|
| Phase | PHASE1 |
| Status | COMPLETED |
| Enrolment | 69 |
| Start date | Thu Jul 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Wed Dec 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Healthy
Interventions
- HEC113995PA•H2O tablet
- Placebo tablet
Countries
China